Literature DB >> 10342643

Long-term non-progression in HIV infection: clinico pathological issues.

S Rowland-Jones1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10342643     DOI: 10.1016/s0163-4453(99)90070-1

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  5 in total

Review 1.  GB virus type C: a beneficial infection?

Authors:  Jack T Stapleton; Carolyn F Williams; Jinhua Xiang
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

2.  Design and preclinical development of a recombinant protein and DNA plasmid mixed format vaccine to deliver HIV-derived T-lymphocyte epitopes.

Authors:  Leslie E Walker; Lo Vang; Xuefei Shen; Brian D Livingston; Penny Post; Alessandro Sette; C Steven Godin; Mark J Newman
Journal:  Vaccine       Date:  2009-09-26       Impact factor: 3.641

3.  Possession of human leucocyte antigen DQ6 alleles and the rate of CD4 T-cell decline in human immunodeficiency virus-1 infection.

Authors:  Annapurna Vyakarnam; David Sidebottom; Shahed Murad; James A Underhill; Philippa J Easterbrook; Angus G Dalgleish; Mark Peakman
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

4.  DNA vaccine encoding human immunodeficiency virus-1 Gag, targeted to the major histocompatibility complex II compartment by lysosomal-associated membrane protein, elicits enhanced long-term memory response.

Authors:  Luciana Barros de Arruda; Priya R Chikhlikar; J Thomas August; Ernesto T A Marques
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

5.  HIV-1-specific CD4+ T cell responses in chronically HIV-1 infected blippers on antiretroviral therapy in relation to viral replication following treatment interruption.

Authors:  Emmanouil Papasavvas; Jay R Kostman; Brian Thiel; Maxwell Pistilli; Agnieszka Mackiewicz; Andrea Foulkes; Robert Gross; Kimberly A Jordan; Douglas F Nixon; Robert Grant; Jean-Francois Poulin; Joseph M McCune; Karam Mounzer; Luis J Montaner
Journal:  J Clin Immunol       Date:  2006-01       Impact factor: 8.542

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.